{
  "trial_id": "NCT02678949",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Informed written consent signed by a parent or guardian of the patient and assent if signed by the patient.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients from 7 to 17 years of age with a diagnosis of mild or moderate asthma according to the criteria of the Global Initiative for Asthma 2014 (Global Strategy for Asthma Management and Prevention. National Institutes of Health 2014), treated with inhaled steroids and who come to the outpatient clinic of Pediatric Pulmonology Service of Hospital Infantil de Mexico.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "An evolution of the asthma > 6 months.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Control subjects (healthy) from 7 to 17, which will be contacted by telephone in accordance with a list that is counted in the Laboratory of Pulmonary Physiology who have participated in other studies or bioassays for calibration of equipment.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Able to perform spirometry test and multiple-breath washout.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "No exacerbation of asthma in the past 4 weeks.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Accept a washout period (without treatment) for 1 week before the realization of studies of pulmonary function (visit 2).",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Accept the use of short-acting B2 as necesary reason.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Do not suffer from any other chronic disease, other than asthma.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Patients with a diagnosis of severe asthma according to criteria of the Global Initiative for Asthma 2014 (Global Strategy for Asthma Management and Prevention. National Institutes of Health 2014),",
      "label": "not_met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patient with acute or chronic pulmonary disease other than asthma.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Sample size; Taking into account the magnitude of the effect on the LCI during the MBW in pediatric subjects with asthma, pre and postbronchodilation on the basis of clinical studies carried out previously (Singer F, Abbas Ch, Yammine S, Casaulta C, Frey U, Latzin P. Abnormal small airway function in children with mild asthma.) Chest 2014; 145 (3): 492-499). Where the rate of LCI prebronchodilator was 2.96 \u00b1 1.6 and the 20 minutes postbroncodilatador the clearance rate was 1.83 \u00b1 1.24. Considering that the magnitude of the effect on the rate of LCI is 1.13, with standard deviation of 1.6. With a \u03b1 = 0.05 (bilateral), \u03b2 = 0.20, 80% statistical power. The sample size will be of 30 patients per group, taking into account a greater loss of 20%, the sample size will be increased to 35 subjects per group.",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient is a 15-year-old boy with asthma diagnosed a year ago. He presents with shortness of breath, chest tightening and cough. According to his mother, he didn't respond to the usual corticosteroid inhaler.",
  "_meta": {
    "topic_id": "59",
    "trial_id": "NCT02678949",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}